Close Menu

Mass Spec

News on mass spectrometry technology and applications in genetics, genomics, and molecular diagnostics.

Agilent has partnered with the National University of Singapore and National University Hospital to establish the S$38 million ($27.4 million) research and development facility in Singapore.

The study authors said that the technique could help researchers better prioritize which of the vast number of protein PTMs to investigate more thoroughly.

When blood amyloid levels are combined with other risk factors, people with early Alzheimer's brain changes can be identified with high accuracy.

The firm had revenues of $6.32 billion in Q2, up 4 percent from $6.08 billion last year and just beating the average Wall Street estimate of $6.3 billion.

The UK company plans to launch a CE-IVD version of the test in 2021 and anticipates launch of an FDA-cleared test shortly thereafter.